Exact Science, ALTUS2021-01, at Risk for Hepatocellular Ca (HCC), Multi-Target Test Oncoguard

Summary

Primary Objective: Assess overall sensitivity and specificity of Oncoguard Liver for hepatocellular cancer (HCC) detection in a surveillance population. Secondary Objective(s): Assess performance of Oncoguard Liver in confirmed HCC and non-HCC population. Assess early-stage sensitivity of Oncoguard Liver for HCC detection in a surveillance population.


Inclusion Criteria

  • All Subjects:
  • Subject is 18 years of age or older
  • Subject understands the study procedures and is able to provide informed consent to participate in the study and authorization for release of data, including personal health data, to the study investigator and sponsor
Show more

Study Location(s)

Cedars-Sinai Cancer at SOCC

More about this Clinical Trial

Full Title

ALTUS2021-01: ALTUS: Performance of a Multi-Target Hepatocellular Carcinoma Test in Subjects with Increased Risk

Details
Disease Type/Condition

Liver

Principal Investigator

Yang, Ju Dong

Co-Investigators

Walid Ayoub

Age Group

Adult

Phase

N/A (Cancer Control)

IRB Number

STUDY00001693

ClinicalTrials.gov ID

NCT03628651

Key Eligibility
ClinicalTrials.gov

Contact
Phone
310-423-6252
Email
clinicaltrials@cshs.org
Want to join the study or
learn more?

Details
Disease Type/Condition

Liver

Principal Investigator

Yang, Ju Dong

Age Group

Adult

Phase

N/A (Cancer Control)

IRB Number

ALTUS2021-01

ClinicalTrials.gov ID

NCT03628651

Key Eligibility
ClinicalTrials.gov

Contact
Phone
310-423-6252
Email
clinicaltrials@cshs.org
Want to join the study or
learn more?